Articles On Race Oncology (ASX:RAC)
| Title | Source | Codes | Date |
|---|---|---|---|
|
Revealed: These 4 ASX mining stocks are rocketing as the rare earths boom intensifies
Lynas Rare Earths Ltd (ASX: LYC) has been a star performer so far in 2025 with its share price soaring by 203% to $19.81 by Friday's close. The company operates the Mt Weld mine in Western Australia which is widely regarded as one of the... |
Motley Fool | RAC | 5 months ago |
|
Scott Power: ASX health stocks lift in good news week across sector
ASX health sector moved up 1.30% for the week, while broader market inched up 0.12% This week: PainChek’s groundbreaking digital app scored coveted FDA De Novo clearance; The FDA lifted a clinical hold on Neurizon’s lead drug candidate for... |
Stockhead | RAC | 5 months ago |
|
HotCopper Highlights: Findi says its lawyers will deal with incident on the forums; Race hits all time high & more
Good Afternoon and welcome to HotCopper Highlights wrapping up Week 41 of the year, I’m Jon Davidson. In this segment the top stocks most watched and most discussed by you, HotCopper users, let’s get straight into it starting with the most... |
themarketonline.com.au | RAC | 5 months ago |
|
If I'd put $3k into this ASX mining stock at the start of 2025, I'd now have $495,000
Very few investors had heard of Dateline Resources Ltd (ASX: DTR) at the start of the year. In early January, shares in this ASX mining stock were changing hands at $0.003 per share, with its market capitalisation clocking in at less th... |
Motley Fool | RAC | 5 months ago |
|
Market Close: A green day at least, but fairly uneventful – how Friday goes is anybody’s guess
Good Afternoon and welcome to HotCopper’s Market Close for Thursday 9th of October. At least it was a green day! The XJO was tracking for a flattish green finish in the final moments of Thursday intraday trades. Materials was in the lead... |
themarketonline.com.au | RAC | 5 months ago |
|
Listen: HotCopper Wire Podcast 028 – Cboe wants ASX’s cake; ATHs for two safe havens
Welcome to this week’s HotCopper Wire, our market watch podcast! Each week, HotCopper’s senior markets reporter Jonathon Davidson and I take you through the week’s biggest news headlines — and what they mean for Oz investors. In this Wee... |
themarketonline.com.au | RAC | 5 months ago |
|
7 ASX small-cap gold shares skyrocketing in 2025
ASX gold shares are having an incredible run in 2025 amid the gold price soaring above US$4,000 per ounce for the first time overnight. At the time of writing, the gold price is US$4,011 per ounce, representing an astonishing 53% gain i... |
Motley Fool | RAC | 5 months ago |
|
ASX Market Update: Mining, Gold & Renewable Trends
Highlights Riversgold expands Kalgoorlie footprint Lithium Universe achieves solar recycling breakthrough Aurum Resources upgrades Boundiali project Explore recent developments in ASX mining stocks, gold exploration, and renewable... |
Kalkine Media | RAC | 5 months ago |
|
Closing Bell: ASX holds the line, finishing week on top; IT crowd switches on
ASX holds firm as oil spills, gold dips and tech sector surges Cannon-Brookes stirs up AGL climate clash DigiCo Eagers and Mesoblast fly high By the close of Friday, the ASX’s 0.46% gain looked pretty darn respectable considering oil’s... |
Stockhead | RAC | 6 months ago |
|
Scott Power: ASX health stocks rise; Race Oncology enjoys big week with lead drug discovery
ASX heath sector up 2.84% for the week, while broader market rises ~2.4% Morgans Scott Power said sector showing signs of recovery heading into year end Race Oncology rises almost 30% this week after discovery in development of lead cardio... |
Stockhead | RAC | 6 months ago |
|
HotCopper Highlights, Week 40: Invictus again, Metallium-Glencore hope, Race Oncology, and more
Happy Friday, and welcome to HotCopper Highlights for Week 40 – I’m Isaac McIntyre, covering for Jonathon Davison while he’s off celebrating his birthday. In this segment, we’ll be looking at all the most popular stocks on Australia’s #1 fi... |
themarketonline.com.au | RAC | 6 months ago |
|
Long Shortz with Race Oncology: Understanding the mechanism of action that could transform cancer therapy
Host Tylah Tully sits down with Race Oncology (ASX:RAC) CEO Daniel Tillett to discuss the groundbreaking discovery of the primary mechanism of action of their lead drug. Tillett explains how understanding the drug’s mechanism increases the... |
Stockhead | RAC | 6 months ago |
|
Race Oncology boosted by discovery of (E,E)-bisantrene’s anticancer mechanism
Race identifies primary mechanism of action for (E,E)-bisantrene (RCDS1), the active compound underpinning its lead candidate RC220 drug Targeting G4-DNA and RNA structures by RCDS1 reduces the activity of many important cancer genes, incl... |
Stockhead | RAC | 6 months ago |
|
ASX September Winners: ASX breaks five-month winning streak but small caps hold ground
After five months of consecutive gains, the ASX 200 fell 0.78% in September with nine of 11 sectors in the red Smaller companies performed strongly with the ASX Emerging Companies and ASX Small Ordinaries rising 13% and 3% respectively Emb... |
Stockhead | RAC | 6 months ago |
|
Closing Bell: ASX in fine fettle, up more than 1pc on healthcare and mining strength
ASX goes on the offence, up 1.13pc 8 of 11 sectors higher, led by healthcare and materials Strength in resources, banks and healthcare drive gains ASX roars higher, rotating back out of defensive sectors After playing it safe yesterday,... |
Stockhead | RAC | 6 months ago |
|
Up more than 125% in a year, can this ASX 200 stock rise further?
The S&P/ASX 200 Index (ASX: XJO) is climbing higher today, up 1.27% at the time of writing. For the year, it is 9.27% higher. It's decent growth for the past 12-month period, but there is one stock that has far outpaced the index and... |
Motley Fool | RAC | 6 months ago |
|
Race Oncology Identifies Breakthrough Anticancer Mechanism for Bisantrene (RCDS1)
Race Oncology (ASX: RAC) has discovered the primary anticancer mechanism of action for its lead drug candidate (E,E)-bisantrene, also known as RCDS1. New studies show the compound acts by binding to special DNA and RNA structures called G-q... |
SmallCaps | RAC | 6 months ago |
|
Thursday’s HotCopper trends: Race Oncology, MTM, and other daily winners | Oct 2
With more than seven million users on the HotCopper forums, every discussion and speculation can move Australian markets, which is why getting out in front of those trends is so important for any trader worth their salt. Listen to the Ho... |
themarketonline.com.au | RAC | 6 months ago |
|
Why Bravura, Dateline, Orthocell, and Race Oncology shares are storming higher
The S&P/ASX 200 Index (ASX: XJO) is back on form and racing higher on Thursday. In afternoon trade, the benchmark index is up 1.05% to 8,939.4 points. Four ASX shares that are rising more than most today are listed below. Here's why t... |
Motley Fool | RAC | 6 months ago |
|
Is your superannuation fund up to scratch? See which six funds have earned the Chantwest-backed Epic Retirement Tick
Superannuation fund research house Chantwest has teamed up with retirement educator Bec Wilson on a new rating â the Epic Retirement Tick â and the bad news is only six out of Australia's more than 60 super funds have made the grade.... |
Motley Fool | RAC | 6 months ago |
|
Cancer drug developer's shares race to three-year high, up 20% on new research results
Race Oncology Ltd (ASX: RAC) shares have opened more than 20% higher after the company released positive cancer research data. The company's stock reached $3.74 in early trading, up 20.2%, marking a new high for the year and a three-year... |
Motley Fool | RAC | 6 months ago |
|
Meet the newest ASX ETF from Betashares
At the time of writing, there are roughly 380 ASX ETFs for investors to choose from. However, in recent years, there has been more and more with more specific themes like AI, tech, or sustainability. Other times, new ETFs come... |
Motley Fool | RAC | 6 months ago |
|
Race Oncology indentifies ‘primary mechanism of action’ of its lead anticancer candidate
Race Oncology (ASX:RAC) has announced the discovery of the primary mechanism of action of its lead anticancer candidate, (E,E)-bisantrene (RCDS1). Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest h... |
themarketonline.com.au | RAC | 6 months ago |
|
ASX Market Open: Three-day Wall Street rally to outshine Oz’s RBA melancholy | Oct 2
Australian shares are heading towards a +0.5% jump at open, with Aussie traders unable to ignore the three-day rally Wall Street has been tearing through in Week 40 – and it’s even enough to beat the RBA hangover. Listen to the HotCopper... |
themarketonline.com.au | RAC | 6 months ago |
|
HotList Stocks: Advance, Red Mountain, and other trending Week 39 companies
Good afternoon, and welcome to the HotCopper HotList Top 10. Every week, hundreds of companies go through the ups and downs of the ASX trading rollercoaster, with fortunes made and equity lost each time the Aussie bourse opens – which is wh... |
themarketonline.com.au | RAC | 6 months ago |
|
HotCopper Highlights, Week 39: Invictus Energy doubts anew; Vection joins the defence club, Larvotto & more
A happy Friday to you and welcome to HotCopper Highlights for Week 39 of the year, I’m Jon Davidson. In this segment we look at the most popular stocks on Australia’s #1 finance and stock research website, which means which stocks you were... |
themarketonline.com.au | RAC | 6 months ago |
|
2 ASX stocks that could 10x your $15,000
Every investor dreams of finding the next ASX stock that can turn a modest investment into a small fortune. While there are no guarantees in the market, history shows that some businesses do manage to grow far beyond expectations. With that... |
Motley Fool | RAC | 6 months ago |
|
Market Close: It’s looking like a return to 9,000pts will be a Santa Rally – but explorers are hardly paying attention
Good Afternoon and welcome to HotCopper’s Market Close, I’m Jon Davidson – note today’s Close is an article only. What a day! We’re on the cusp of Week 40 of 2025 and it’s looking like a return to 9,000pts will probably be a thing of the Sa... |
themarketonline.com.au | RAC | 6 months ago |
|
Does Macquarie rate this ASX 200 mining stock a buy, hold or sell?
Deterra Royalties Ltd (ASX: DRR) shares are tumbling on Thursday. In afternoon trade, the ASX 200 mining stock is down over 6% to $3.92. This means the mining royalties company's shares have given back yesterday's gains and more. Is this a... |
Motley Fool | RAC | 6 months ago |
|
Exploring Recent Developments in the Mining and Biotech Sectors
Highlights Yandal Resources Ltd (YRL) has expanded its Arrakis gold discovery by 400 metres, confirming a continuous mineralized system over a 2.2-kilometre trend. Race Oncology Ltd (RAC) has received approval from the Republic of Kore... |
Kalkine Media | RAC | 6 months ago |
|
Closing Bell: ASX plunges as Wall Street falters and inflation comes in hot
ASX falls 81 points or 0.92pc by end of trade Utilities and energy sectors the only resistance Financials hit hardest, undercut by inflation numbers ASX returns to September form The ASX 200 is in a snit once again, pulling sharply back i... |
Stockhead | RAC | 6 months ago |
|
Here are the top 10 ASX 200 shares today
The S&P/ASX 200 Index (ASX: XJO) endured a rather savage pullback this Wednesday, as investors pulled back after the strong start to the week that we saw over the past two trading days. As of today's... |
Motley Fool | RAC | 6 months ago |
|
Race Oncology gets Korean IND approval for clinical trial in solid tumour patients
RAC welcomes Investigational New Drug approval for cancer treatment in Korea Company plans to start patient recruitment shortly at four sites for the Phase 1 clinical trial Korean MFDS IND approval rigour is similar to that provided by the... |
Stockhead | RAC | 6 months ago |
|
Market Close: We were already in for a milquetoast day, then headline CPI came in at 3%
Good Afternoon and welcome to HotCopper’s Market Close for Wednesday 24th of September, I’m Jon Davidson. It was a bad start to the day as far as getting back towards 9,000pts goes, and then it got worse. We learned today that Australian he... |
themarketonline.com.au | RAC | 6 months ago |
|
Race Oncology’s 180% month on month rally continues with fresh approval from Korean drug regulator
Race Oncology (ASX:RAC) has received approval for an investigational new drug (IND) from Korea’s health and drug regulator MFDS, with a phase one clinical trial for Race’s RC220 drug of interest now to go ahead in the Republic. Listen to... |
themarketonline.com.au | RAC | 6 months ago |
|
Why Deterra Royalties, DroneShield, Lindian, and Race Oncology shares are rising today
In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a disappointing decline. At the time of writing, the benchmark index is down 1% to 8,758.7 points. Four ASX shares that are not letting that hold them back are... |
Motley Fool | RAC | 6 months ago |
|
Health Check: Imagion is crossing the t’s and dotting the i’s on crucial breast imaging trial submission
Current cancer imaging tools are “not good enough”, Imagion chief Bob Proulx says Micro-x announces second grant in the space of two days Race Oncology wins Korean trial assent … in South Korea, of course Imagion Biosystems (ASX:IBX) sa... |
Stockhead | RAC | 6 months ago |
|
Looking for a biotech multi-bagger? This could be the one.
Biotechnology stocks can be high-risk but also high-reward. The key is latching on to one with a promising product pipeline and the ability to bring it to market. Wilsons Advisory's healthcare analysts believe Immutep Ltd (ASX: IMM) may... |
Motley Fool | RAC | 6 months ago |
|
Up 409% in a year, guess which ASX All Ords gold stock is rocketing again today
The All Ordinaries Index (ASX: XAO) is down in morning trade today, but that's not holding back this rocketing ASX All Ords gold stock. The surging miner in question is Barton Gold Holdings Ltd (ASX: BGD). Barton Gold only officially joined... |
Motley Fool | RAC | 6 months ago |
|
Guess which ASX All Ords share is up 9% on 'important milestone'
The market may be tumbling today, but that hasn't stopped one ASX All Ords share from racing higher. Its shares are up a sizeable 9% to $3.26 at the time of writing. Which ASX All Ords share? The share in question today is Race Oncology Ltd... |
Motley Fool | RAC | 6 months ago |
|
Closing Bell: ASX climbs on healthcare strength as PME and TLX jump
ASX pares back early gains to lift 0.32pc Healthcare, tech, utilities drive gains Resources sector drags as gold prices slip from highs ASX gets clean bill of health The ASX was looking a little healthier today, adding 0.32% or 28.3 poi... |
Stockhead | RAC | 6 months ago |
|
HotList Stocks: GoldArc, Auravelle, and other trending Week 38 companies
Good afternoon, and welcome to the HotCopper HotList Top 10. Every week, hundreds of companies go through the ups and downs of the ASX trading rollercoaster, with fortunes made and equity lost each time the Aussie bourse opens – which is wh... |
themarketonline.com.au | RAC | 6 months ago |
|
Long Shortz with Race Oncology: Investor insight into Race’s patent breakthrough
Tylah Tully chats with Race Oncology (ASX:RAC) CEO Dr Daniel Tillett about the company’s major breakthrough submitting a new composition of matter patent application for the Ee-bisantrene compound. Race has identified the long-studied canc... |
Stockhead | RAC | 6 months ago |
|
Closing Bell: ASX emerges from yesterday’s hole as big miners lead the way
ASX closes in the green on positive trading day for energy and resources Big-gun miners help bring bourse back out of the tunnel Goldies rally, too – and we may as well keep this bullet point as standard for the moment The ASX closed 0.... |
Stockhead | RAC | 6 months ago |
|
Race files key patents after major bisantrene discovery, boosting commercial prospects
Race Oncology scientists find a new way of patenting the active chemical form of bisantrene New composition of matter patent application submitted which, if granted, will provide IP protection for 20 years Race says the discovery fundament... |
Stockhead | RAC | 6 months ago |
|
Tuesday’s HotCopper trends: Race Oncology, Paladin Energy, and other daily winners | Sep 16
With more than seven million users on the HotCopper forums, every discussion and speculation can move Australian markets – which is why getting out in front of those trends is so important for any trader worth their salt. Listen to the H... |
themarketonline.com.au | RAC | 6 months ago |
|
ASX 200 Pulse: Gold Momentum, Energy Moves, and Corporate Shake-Ups Driving Market Buzz
Highlights Gold stocks continued to show strength alongside energy counters Major developments shaped trading in leading mining and retail companies Corporate actions created headlines across large and small-cap segments... |
Kalkine Media | RAC | 6 months ago |
|
Why did this ASX All Ords healthcare share just rocket 28%?
The All Ordinaries Index (ASX: XAO) is up 0.3% in morning trade today, with plenty of help from this surging ASX All Ords healthcare share. The rocketing stock in question is clinical stage biopharmaceutical company Race Oncology Ltd (ASX:... |
Motley Fool | RAC | 6 months ago |
|
Market Close: September sell-off continues; gold miners scraped & Middle East lithium rumours
Good Afternoon and welcome to Market Close for Monday 15 September, I’m Jon Davidson. September sell-off season continues, and that was evident today across gold miners as investors take the downturn to scrape profits. After gold prices hav... |
themarketonline.com.au | RAC | 6 months ago |
|
ASX 200 Midday Pulse: Energy Strains, Health Checks, and Materials Reset
Highlights Energy names face operational and cost headwinds Healthcare heavyweights and med-tech reprice expectations Materials narrative pivots as gold output guidance tightens Midday trade turns cautious: energy face... |
Kalkine Media | RAC | 6 months ago |